cro.directory
← Compare landing

Aragen Life Sciences vs Nucro-Technics

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/aragen/nucro-technics

CategoryAragen Life SciencesNucro-Technics
Listed sitecrocro
SummaryGlobal CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.Canada's largest privately owned CRO specializing in GMP and GLP testing for pharmaceutical, biologic, and medical device companies. Offers analytical chemistry, microbiology, toxicology, bioanalytical, and genetic toxicology services with over 50 years of experience.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Protein Engineering
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Specialized & Large-Animal Models
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • Microbiology Services
  • GLP Toxicology
  • Safety Pharmacology
  • Genetic Toxicology
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Bioanalysis
  • Regulatory Affairs
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
Data not yet provided.
Indications
  • Oncology
  • Immunology
  • Neurology
  • Psychiatry
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Dermatology
  • Ophthalmology
  • Gastroenterology
  • Nephrology
  • Women's Health
Data not yet provided.
Locations
  • Global Headquarters, Hyderabad, Telangana, India
  • R&D and Manufacturing Campus, Hyderabad, Telangana, India
  • R&D Campus, Hyderabad, Telangana, India
  • Manufacturing Campus, Visakhapatnam, Andhra Pradesh, India
  • R&D Campus, Bengaluru, Karnataka, India
  • Biosafety Solutions, Pune, Maharashtra, India
  • Regional Office, New Delhi, Delhi, India
  • Sales Office, Tokyo, Japan
  • Sales Office, Seoul, South Korea
  • Sales Office, Cambridge, Massachusetts, USA
  • R&D Campus, Morgan Hill, California, USA
  • Sales Office, Utrecht, Netherlands
  • Sales Office, Milan, Italy
  • Sales Office, South Korea
  • Global Headquarters & R&D and Manufacturing Campus, Hyderabad, Telangana, India
  • R&D Campus, Pune, Maharashtra, India
  • R&D Campus, New Delhi, Delhi, India
  • Sales Office, New Jersey, New Jersey, USA
  • Global Headquarters, R&D and Manufacturing Campus, Hyderabad, Telangana, India
  • R&D Campus, Mallapur, Hyderabad, India
  • Headquarters, Toronto, Ontario, Canada
Certifications
  • USFDA · Identifier: EIR for Nacharam Unit 1
  • Standards Council of Canada · Identifier: OECD GLP Standard
  • ISO · Identifier: ISO 9001:2015
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.